880 related articles for article (PubMed ID: 25318835)
1. New treatments for the motor symptoms of Parkinson's disease.
Vijverman AC; Fox SH
Expert Rev Clin Pharmacol; 2014 Nov; 7(6):761-77. PubMed ID: 25318835
[TBL] [Abstract][Full Text] [Related]
2. Drugs and drug delivery in PD: optimizing control of symptoms with pramipexole prolonged-release.
Rascol O
Eur J Neurol; 2011 Mar; 18 Suppl 1():3-10. PubMed ID: 21255197
[TBL] [Abstract][Full Text] [Related]
3. Non-dopaminergic treatments for motor control in Parkinson's disease.
Fox SH
Drugs; 2013 Sep; 73(13):1405-15. PubMed ID: 23917951
[TBL] [Abstract][Full Text] [Related]
4. New treatments for levodopa-induced motor complications.
Rascol O; Perez-Lloret S; Ferreira JJ
Mov Disord; 2015 Sep; 30(11):1451-60. PubMed ID: 26293004
[TBL] [Abstract][Full Text] [Related]
5. Safinamide for the treatment of Parkinson's disease.
Kandadai RM; Jabeen SA; Kanikannan MA; Borgohain R
Expert Rev Clin Pharmacol; 2014 Nov; 7(6):747-59. PubMed ID: 25300164
[TBL] [Abstract][Full Text] [Related]
6. Emerging drugs for levodopa-induced dyskinesia.
Al Dakheel A; Beaulieu-Boire I; Fox SH
Expert Opin Emerg Drugs; 2014 Sep; 19(3):415-29. PubMed ID: 25146568
[TBL] [Abstract][Full Text] [Related]
7. Levodopa in the treatment of Parkinson's disease: current status and new developments.
Salat D; Tolosa E
J Parkinsons Dis; 2013 Jan; 3(3):255-69. PubMed ID: 23948989
[TBL] [Abstract][Full Text] [Related]
8. New and emerging medical therapies in Parkinson's disease.
Lotia M; Jankovic J
Expert Opin Pharmacother; 2016; 17(7):895-909. PubMed ID: 26830844
[TBL] [Abstract][Full Text] [Related]
9. Drugs for Parkinson's disease.
Treat Guidel Med Lett; 2013 Nov; 11(135):101-6. PubMed ID: 24165688
[TBL] [Abstract][Full Text] [Related]
10. Safety of IPX066 , an extended release carbidopa-levodopa formulation, for the treatment of Parkinson's disease.
Kestenbaum M; Fahn S
Expert Opin Drug Saf; 2015 May; 14(5):761-7. PubMed ID: 25697185
[TBL] [Abstract][Full Text] [Related]
11. Drug insight: Continuous dopaminergic stimulation in the treatment of Parkinson's disease.
Olanow CW; Obeso JA; Stocchi F
Nat Clin Pract Neurol; 2006 Jul; 2(7):382-92. PubMed ID: 16932589
[TBL] [Abstract][Full Text] [Related]
12. Contemporary Options for the Management of Motor Complications in Parkinson's Disease: Updated Clinical Review.
Cabreira V; Soares-da-Silva P; Massano J
Drugs; 2019 Apr; 79(6):593-608. PubMed ID: 30905034
[TBL] [Abstract][Full Text] [Related]
13. Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life.
Fasano A; Ricciardi L; Lena F; Bentivoglio AR; Modugno N
Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):79-89. PubMed ID: 22338551
[TBL] [Abstract][Full Text] [Related]
14. Maximizing the benefit:risk ratio of levodopa therapy in Parkinson's disease.
Gottwald MD
Pharmacotherapy; 1999 Nov; 19(11 Pt 2):162S-8S. PubMed ID: 10555944
[TBL] [Abstract][Full Text] [Related]
15. [Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease].
Klivényi P; Vécsei L
Ideggyogy Sz; 2007 Jan; 60(1-2):61-4. PubMed ID: 17432097
[TBL] [Abstract][Full Text] [Related]
16. IPX066: a novel carbidopa-levodopa extended-release formulation.
Hauser RA
Expert Rev Neurother; 2012 Feb; 12(2):133-40. PubMed ID: 22288668
[TBL] [Abstract][Full Text] [Related]
17. Treatment of motor fluctuations in Parkinson's disease: recent developments and future directions.
Ramirez-Zamora A; Molho E
Expert Rev Neurother; 2014 Jan; 14(1):93-103. PubMed ID: 24328720
[TBL] [Abstract][Full Text] [Related]
18. Current and experimental treatments of Parkinson disease: A guide for neuroscientists.
Oertel W; Schulz JB
J Neurochem; 2016 Oct; 139 Suppl 1():325-337. PubMed ID: 27577098
[TBL] [Abstract][Full Text] [Related]
19. Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications.
Olanow CW; Obeso JA; Stocchi F
Lancet Neurol; 2006 Aug; 5(8):677-87. PubMed ID: 16857573
[TBL] [Abstract][Full Text] [Related]
20. Current strategies in the drug treatment of advanced Parkinson's disease--new modes of dopamine substitution.
Schelosky L; Poewe W
Acta Neurol Scand Suppl; 1993; 146():46-9. PubMed ID: 8101415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
